Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. MorphoSys AG
  6. News
  7. Summary
    MOR   DE0006632003

MORPHOSYS AG

(MOR)
  Report
Real-time Estimate Tradegate  -  02:51 2022-12-01 am EST
15.47 EUR   -0.59%
11/28Morphosys Ag : Financial Calendar 2023
EQ
11/28Morphosys : Notification of managers`transactions according to article 19 MAR - Form 6-K
PU
11/28Dd : MorphoSys AG: Krisja Vermeylen, buy
EQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Days
:
Hours
:
Minutes
:
Seconds

European ADRs Move Higher in Wednesday Trading

09/28/2022 | 11:06am EST


ę MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
AKARI THERAPEUTICS, PLC 2.30% 0.5526 Delayed Quote.-63.16%
AMARIN CORPORATION PLC 0.88% 1.15 Delayed Quote.-65.88%
AVADEL PHARMACEUTICALS PLC 16.96% 9.17 Delayed Quote.13.49%
BARCLAYS PLC 0.15% 161.24 Delayed Quote.-13.78%
DBV TECHNOLOGIES -0.58% 2.746 Real-time Quote.-10.23%
ENDAVA PLC 8.39% 76.71 Delayed Quote.-54.32%
ERYTECH PHARMA S.A. -3.31% 0.6285 Real-time Quote.-70.35%
GRIFOLS, S.A. 2.12% 10.155 Delayed Quote.-39.82%
HSBC HOLDINGS PLC -0.12% 509.7 Delayed Quote.13.61%
LLOYDS BANKING GROUP PLC 1.25% 46.905 Delayed Quote.-1.87%
MORPHOSYS AG 2.03% 15.565 Delayed Quote.-53.33%
NOVO NORDISK A/S 0.47% 884 Delayed Quote.20.27%
PRUDENTIAL PLC 1.51% 979.4 Delayed Quote.-23.15%
SEQUANS COMMUNICATIONS S.A. 8.16% 3.71 Delayed Quote.-21.73%
VEON LTD. 0.00% 0.6 Delayed Quote.-64.91%
VOXELJET AG -5.74% 2.64 Delayed Quote.-52.53%
All news about MORPHOSYS AG
11/28Morphosys Ag : Financial Calendar 2023
EQ
11/28Morphosys : Notification of managers`transactions according to article 19 MAR - Form 6-K
PU
11/28Dd : MorphoSys AG: Krisja Vermeylen, buy
EQ
11/25MORPHOSYS : Deutsche Bank keeps a Sell rating
MD
11/21Morphosys : Notification of managers`transactions according to article 19 MAR - Form 6-K
PU
11/21Dd : MorphoSys AG: Dr. Marc Cluzel, buy
EQ
11/18MORPHOSYS : JP Morgan sticks Neutral
MD
11/17Transcript : MorphoSys AG, Q3 2022 Earnings Call, Nov 17, 2022
CI
11/17MORPHOSYS : JP Morgan remains Neutral
MD
11/16MorphoSys AG Reports Earnings Results for the Third Quarter and Nine Months Ended Septe..
CI
More news
Analyst Recommendations on MORPHOSYS AG
More recommendations
Financials
Sales 2022 233 M 241 M 241 M
Net income 2022 -481 M -496 M -496 M
Net Debt 2022 - - -
P/E ratio 2022 -1,18x
Yield 2022 -
Capitalization 531 M 548 M 548 M
Capi. / Sales 2022 2,28x
EV / Sales 2023 1,75x
Nbr of Employees 627
Free-Float 97,5%
Chart MORPHOSYS AG
Duration : Period :
MorphoSys AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MORPHOSYS AG
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 10
Last Close Price 15,57 €
Average target price 27,70 €
Spread / Average Target 78,0%
EPS Revisions
Managers and Directors
Jean-Paul Kress CEO & Chairman-Management Board
Sung H. Lee Chief Financial Officer
Marc Cluzel Chairman-Supervisory Board
Tim Demuth Chief Research & Development Officer
Krisja Vermeylen Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
MORPHOSYS AG-53.33%548
MODERNA, INC.-31.83%66 521
IQVIA HOLDINGS INC.-22.73%39 470
LONZA GROUP AG-36.15%37 899
ALNYLAM PHARMACEUTICALS, INC.30.08%25 195
SEAGEN INC.-21.48%21 791